Buy Mounjaro online in australia from Onlinepharmaustralia. Wegovy contains semaglutide and is administered as a once-weekly injection. For adults using Wegovy for an approved chronic weight-management indication, treatment normally begins at a low dose and increases gradually before reaching the maintenance phase.
The standard adult Wegovy maintenance dose is 2.4 mg once weekly. The dose is reached gradually over the first 16 weeks of treatment rather than being used from the beginning.
However, 2.4 mg is not a dose that patients should increase to independently. A healthcare professional should determine the appropriate treatment schedule and review tolerability throughout treatment.
This guide explains what the Wegovy maintenance dose means, when it is reached, why dose escalation is gradual, what happens if 2.4 mg is not tolerated and what patients should know about long-term treatment.
What Is the Wegovy Maintenance Dose?
The Wegovy maintenance dose is the dose used after the initial dose-escalation period.
For standard adult weight-management treatment, the Australian Product Information identifies:
2.4 mg once weekly
as the maintenance dose.
The maintenance phase follows a gradual escalation:
| Treatment period | Weekly dose |
|---|---|
| Weeks 1–4 | 0.25 mg |
| Weeks 5–8 | 0.5 mg |
| Weeks 9–12 | 1 mg |
| Weeks 13–16 | 1.7 mg |
| Maintenance | 2.4 mg |
The purpose of this gradual progression is to help the body adjust to semaglutide and improve tolerability.
When Do You Reach the Wegovy Maintenance Dose?
Under the standard Australian dosing schedule, patients reach the maintenance phase after the initial 16-week dose-escalation period.
The progression is:
Weeks 1–4: 0.25 mg once weekly
5–8: 0.5 mg once weekly
9–12: 1 mg once weekly
Weeks 13–16: 1.7 mg once weekly
After escalation: 2.4 mg once weekly as the usual maintenance dose.
This timetable is a general dosing framework rather than an instruction for an individual patient.
If a patient experiences significant adverse effects, their healthcare professional may decide that the dose should remain unchanged for longer or be adjusted.
Why Doesn’t Wegovy Start at 2.4 mg?
Wegovy is not normally started at the maintenance dose.
The treatment begins with 0.25 mg once weekly and increases every four weeks under the standard schedule.
Gradual escalation helps improve tolerability, particularly because gastrointestinal effects can occur during treatment.
Possible gastrointestinal adverse effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
- Indigestion
If significant gastrointestinal symptoms develop, the dose may need to remain at the current level for longer before another increase is considered.
The Australian Product Information specifically provides for delaying escalation when significant gastrointestinal symptoms occur.
Is 2.4 mg Always the Right Maintenance Dose?
Not necessarily.
Although 2.4 mg once weekly is the standard adult maintenance dose, individual treatment may need to be adjusted.
The Australian Product Information states that if the 2.4 mg dose is not tolerated, the dose can temporarily be reduced to 1.7 mg once weekly, with an attempt to increase back to the recommended maintenance dose later.
This means that patients should not assume they need to reach or remain at 2.4 mg regardless of how they respond.
The appropriate dose is ultimately a clinical decision.
What Happens If You Cannot Tolerate 2.4 mg?
Some patients may experience significant gastrointestinal symptoms or other adverse effects during dose escalation.
If 2.4 mg is difficult to tolerate, a healthcare professional may consider temporarily reducing the dose to 1.7 mg once weekly and later attempting to increase it again when appropriate.
Do not reduce or increase the dose yourself.
Contact your prescribing healthcare professional if you are experiencing persistent or significant symptoms.
Does the Wegovy Maintenance Dose Stay the Same Every Week?
The standard maintenance dose is administered once weekly.
Once a patient has reached the prescribed maintenance dose, the same weekly dose is generally continued unless the healthcare professional decides that an adjustment is appropriate.
The weekly schedule means patients do not normally take a smaller dose on some days and a larger dose on others.
Do not divide or modify your prescribed dose unless specifically instructed by your healthcare professional.
How Often Is the Wegovy Maintenance Dose Taken?
The maintenance dose is taken once a week.
Wegovy can be administered at any time of day, with or without food.
Patients often find it useful to choose a consistent day of the week and use a calendar or medication reminder.
The important point is to follow the schedule provided by your prescriber.
Can You Change the Day of Your Wegovy Maintenance Dose?
The weekly administration day can be changed when necessary.
The Australian Product Information states that there should be at least 72 hours between two doses when changing the day of weekly administration.
After changing the day, continue the once-weekly schedule on the new day.
If you are unsure how to change your injection day, ask your pharmacist or healthcare professional before making the change.
What If You Miss Your Wegovy Maintenance Dose?
The missed-dose instructions also apply during the maintenance phase.
According to the Australian Product Information:
- If the missed dose is within 5 days, administer it as soon as possible.
- If more than 5 days have passed, skip the missed dose.
- Take the next dose on your normal scheduled day.
- Then continue the regular once-weekly schedule.
If several doses have been missed, your healthcare professional may need to consider whether treatment should be restarted at a lower dose.
Do not take an extra injection to compensate for a missed dose.
Can You Increase the Wegovy Maintenance Dose Above 2.4 mg?
For the standard adult weight-management schedule, 2.4 mg once weekly is the recommended maintenance dose.
Patients should not increase the dose above the prescribed amount in an attempt to achieve faster or greater weight loss.
Taking more medicine than prescribed can increase the risk of adverse effects.
If you believe your current dose is no longer appropriate, discuss this with your healthcare professional rather than changing it yourself.
Does a Higher Wegovy Dose Mean More Weight Loss?
It is important not to assume that increasing the dose automatically produces a predictable amount of additional weight loss for an individual.
Wegovy treatment is designed to be used as part of a broader weight-management programme that includes dietary and physical-activity measures. The TGA’s approved adult indication covers chronic weight management, including weight loss and weight maintenance.
Individual responses vary.
Your healthcare professional can assess your treatment response rather than relying on a predetermined weight-loss target.
What Is the Purpose of the Wegovy Maintenance Phase?
The maintenance phase provides an ongoing dose after the initial escalation period.
Wegovy is approved for chronic weight management, which includes both weight loss and weight maintenance in eligible adults.
This is different from viewing Wegovy simply as a short course of injections.
During ongoing treatment, a healthcare professional can review:
- Weight changes
- Appetite and eating patterns
- Treatment response
- Side effects
- Dose tolerance
- Other medicines
- Relevant health conditions
- Long-term treatment goals
How Long Do You Stay on the Wegovy Maintenance Dose?
There is no single treatment duration that applies to every patient.
Wegovy is indicated for chronic weight management, including weight maintenance, so treatment may continue beyond the initial dose-escalation period when clinically appropriate.
The decision to continue treatment should be based on individual circumstances and ongoing medical review.
If you are thinking about stopping Wegovy, speak with your healthcare professional before making changes.
Wegovy Maintenance Dose and Side Effects
Gastrointestinal side effects are among the important tolerability considerations with semaglutide.
These can include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
The TGA updated semaglutide safety information in June 2026 to include additional information concerning gastrointestinal effects, dehydration and more serious gastrointestinal effects in patients with gastroparesis. The update also added information concerning NAION, alopecia and cholecystitis.
Patients should contact a healthcare professional if they develop concerning, severe or persistent symptoms.
Can the Maintenance Dose Be Reduced?
A reduction may be considered when the prescribed maintenance dose is not tolerated.
For Wegovy, the Australian Product Information specifically describes temporarily reducing from 2.4 mg to 1.7 mg once weekly when the 2.4 mg dose is not tolerated, followed by an attempt to return to the recommended maintenance dose.
This should be done under medical supervision.
Patients should not independently switch between Wegovy strengths.
Wegovy Maintenance Dose and Long-Term Weight Management
Maintaining weight after initial weight loss is an important part of chronic weight management.
Wegovy’s Australian indication specifically includes both weight loss and weight maintenance in eligible adults.
The maintenance phase therefore should not be viewed simply as the point at which treatment stops producing changes.
Instead, it is the ongoing stage of treatment where the healthcare professional assesses whether the medicine continues to provide an appropriate balance between benefits, tolerability and treatment goals.
What Should You Do During the Maintenance Phase?
Once you reach your prescribed maintenance dose, continue following your treatment plan.
Useful habits can include:
Take the injection on the scheduled day
A regular weekly routine can make it easier to remember each dose.
Follow your prescribed dose
Do not increase or reduce the dose without medical advice.
Continue healthy lifestyle measures
Wegovy is intended to be used alongside dietary and physical-activity measures for its approved weight-management indication.
Attend follow-up appointments
Your healthcare professional can monitor your response and tolerability.
Report significant side effects
Persistent or severe symptoms should be discussed with your healthcare professional.
Store the medicine correctly
Follow the storage instructions supplied with your specific Wegovy product.
Wegovy Maintenance Dose in Australia
Wegovy is registered in Australia as a prescription medicine containing semaglutide.
The TGA’s current Australian Register of Therapeutic Goods includes a 2.4 mg Wegovy presentation, registered in March 2026.
Healthdirect also lists Wegovy as a Schedule 4 prescription-only medicine.
Patients should therefore obtain and use Wegovy through an appropriate medical and pharmacy pathway.
Wegovy Maintenance Dose vs Starting Dose
The starting and maintenance doses serve different purposes.
| Dose | Role in treatment |
|---|---|
| 0.25 mg | Starting dose |
| 0.5 mg | Dose-escalation stage |
| 1 mg | Dose-escalation stage |
| 1.7 mg | Final standard escalation stage |
| 2.4 mg | Usual adult maintenance dose |
The standard escalation occurs over 16 weeks.
Starting at 2.4 mg is not the standard approach.
Frequently Asked Questions About the Wegovy Maintenance Dose
What is the maintenance dose of Wegovy?
For the standard adult weight-management schedule, the recommended maintenance dose is 2.4 mg once weekly.
When do you reach the 2.4 mg Wegovy dose?
Under the standard schedule, patients progress through four-week periods at 0.25 mg, 0.5 mg, 1 mg and 1.7 mg before reaching the 2.4 mg maintenance dose.
Can you stay on 1.7 mg Wegovy?
If 2.4 mg is not tolerated, the Australian Product Information allows temporary reduction to 1.7 mg, followed by an attempt to increase to the recommended maintenance dose.
The decision should be made with your healthcare professional.
Is 2.4 mg Wegovy taken once a week?
Yes. The standard maintenance dose is 2.4 mg administered once weekly.
Can I take more than 2.4 mg of Wegovy?
Do not exceed the prescribed dose. For the standard adult weight-management schedule, 2.4 mg once weekly is the recommended maintenance dose.
Does everyone need to reach 2.4 mg?
The standard adult schedule is designed to reach 2.4 mg, but treatment can be adjusted if the dose is not tolerated.
Can I stop Wegovy after reaching the maintenance dose?
Do not stop treatment without discussing it with your healthcare professional. Wegovy is approved for chronic weight management, including weight maintenance.
What if I miss my 2.4 mg maintenance dose?
If the missed dose is within 5 days, take it as soon as possible. If more than 5 days have passed, skip it and take the next dose on the normal scheduled day.
Can I reduce my Wegovy maintenance dose if I have side effects?
Dose adjustment may be appropriate when the maintenance dose is not tolerated, but this should be determined by your healthcare professional. The Australian Product Information specifically describes temporary reduction to 1.7 mg in this situation.
Is Wegovy 2.4 mg available in Australia?
Yes. The TGA’s ARTG includes registered 2.4 mg Wegovy presentations in Australia.
Final Thoughts
The Wegovy maintenance dose is an important stage of semaglutide treatment. For the standard adult weight-management schedule in Australia, the usual maintenance dose is 2.4 mg once weekly, reached gradually after the initial 16-week dose-escalation period.
However, reaching 2.4 mg should not be treated as a race. If the dose is not tolerated, treatment may need to be adjusted under medical supervision.
The appropriate maintenance plan depends on your individual response, tolerability and medical circumstances. Continue to follow your prescriber’s instructions and seek medical advice if you experience significant or persistent side effects.
Medical Information Notice: This article is for general educational purposes and does not replace individual medical advice, diagnosis or treatment. Wegovy is a prescription medicine. Always follow the current Australian Product Information, Consumer Medicine Information and instructions provided by your healthcare professional. Medicine information can be updated as new safety information becomes available.